| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Seres Therapeutics, Inc. (MCRB) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. MCRB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 56.3K | $371.3K | - | |
| Other | 22.5K | $148.5K | - | |
| Dir | 11.5K | $75.7K | - | |
| Dir | 11.0K | $72.6K | - | |
| Dir | 10.0K | $66.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 26, 2018 | Shaff Eric D.66 | See Remarks | Sale+OE | 2,780 | $11.02 | $30,635.60 | -34.8% | |
| Jan 26, 2018 | Desrosier Thomas66 | See Remarks | Sale+OE | 3,475 | $11.02 | $38,294.50 | -34.8% | |
| Jan 26, 2018 | Cook David N | See Remarks | Sale+OE | 1,738 | $11.02 | $19,152.76 | -1.2% | |
| Dec 19, 2017 | Aunins John G. | Chief Technology Officer &EVP | Sale+OE | 1,623 | $10.14 | $16,457.22 | -2.7% | |
| Aug 29, 2016 | Aunins John G. | Chief Technology Officer &EVP | Sell | 9,390 | $10.87 | $102,069.30 | -4.7% | |
| Jul 28, 2016 | Trucksis Michele | Chief Medical Officer And EVP | Sale+OE | 4,156 | $35.18 | $146,207.25 | -100% | |
| Jul 27, 2016 | Aunins John G. | Chief Technology Officer &EVP | Sell | 9,250 | $35.00 | $323,750.00 | -4.4% | |
| Jul 27, 2016 | Pomerantz Roger | President And CEO | Sale+OE | 20,000 | $35.00 | $700,000.00 | -9.8% | |
| Jul 27, 2016 | Trucksis Michele | Chief Medical Officer And EVP | Sale+OE | 38,064 | $35.14 | $1,337,511.86 | -100% | |
| Jul 25, 2016 | Aunins John G. | Chief Technology Officer &EVP | Sale+OE | 9,390 | $34.18 | $320,950.20 | -4.3% |